Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2023 Mar 10;47(6):1397–1405. doi: 10.1007/s00264-023-05718-9

The impact of COVID-19 pandemic on the mortality and morbidity of patients undergoing trauma surgery: a report from the UK Corona TRAUMA Surge (UKCoTS) study

Mohamed Imam 1,2,3,, Antony Chi Fung Yiu 1, Ahmed Elgebaly 3, Anshul Sobti 4, Richard E Field 5, Zahra Jaffry 1, Hazem Ghaith 6, Paolo Consigliere 7, Ali A Narvani 1, Rawad Hassan 3, Hassan Abdalla 3; UKCoTS Collaborative
PMCID: PMC9999070  PMID: 36897361

Abstract

Purpose

To assess the impact of the COVID-19 pandemic on the outcomes of the patients who underwent trauma surgery during the peak of the pandemic.

Methods

The UKCoTS collected the postoperative outcomes of consecutive patients who underwent trauma surgery across 50 centres during the peak of the pandemic (April 2020) and during April 2019.

Results

Patients who were operated on during 2020 were less likely to be followed up within a 30-day postoperative period (57.5% versus 75.6% p <0.001). The 30-day mortality rate was significantly higher during 2020 (7.4% versus 3.7%, p <0.001). Likewise, the 60-day mortality rate was significantly higher in 2020 than in 2019 (p <0.001). Patients who were operated on during 2020 had lower rates of 30-day postoperative complications (20.7% versus 26.4%, p <0.001).

Conclusions

Postoperative mortality was higher during the first wave of the COVID-19 pandemic compared to the same period in 2019, but with lower rates of postoperative complications and reoperation.

Keywords: COVID-19, Surgical outcomes, UK, Surgical services

Introduction

Since the World Health Organization (WHO) announced Coronavirus Disease 2019 (COVID-19) as a global pandemic in March 2020, the outbreak has spread worldwide and affected several sectors, leading to substantial socio-economic implications [1]. As of December 2021, nearly 289 million cases were affected by COVID-19, and over 5.4 million deaths were recorded globally [2]. The high replication rate (R0) of the severe acute respiratory syndrome coronavirus-type 2 (SARS-CoV-2) (R0 =2–3)—alongside the high proportion of asymptomatic patients—has led to constant growth in the active cases rate and increased healthcare services demands [3], which exceeded by far the healthcare system preparedness and capacity across the globe [4, 5]. Owing to such an unprecedented challenge, healthcare policymakers and stakeholders implemented several adaptations and response plans to prioritise provided services towards the high volume of COVID-19 patients, face the shortage in emergency healthcare capacity and staff, and limit the spread of COVID-19 amongst healthcare workers [6]. Surgical practices were amongst the early affected sectors. Many centres decided to postpone elective procedures, decrease the number of surgical staff, minimise face-to-face staff meetings, enhance self-prevention measures, mandate SARS-CoV-2 screening for patients before surgery, activate surgical pathways for infected cases, and limit visitors’ time [710].

Nonetheless, a growing body of evidence hypothesised that the COVID-19 impact on surgical practices might affect the outcomes of patients undergoing emergency or elective surgeries [1114]. For example, many centres mandate preoperative SARS-CoV-2 screening, which may limit timely management and compromise the postoperative outcomes of the patients [15]. The direction of the workforce towards intensive care units may result in a shortage of available anaesthesiologists for surgeries. Besides, previous reports indicate that COVID-19-infected patients had poor postoperative outcomes and a high in-hospital mortality rate, putting a further burden on the surgical procedures performed during the pandemic [16, 17]. However, the impact of the COVID-19 pandemic on postoperative outcomes is inconsistent in the published literature. In the PREDICT study, the peak months of the first wave of the pandemic witnessed a notable increase in postoperative mortality [18]. On the contrary, other studies highlighted no difference in postoperative mortality and morbidity between the peak months of the pandemic and the corresponding period before the pandemic [19].

In April 2020, the United Kingdom (UK) witnessed a dramatic increase in the number of COVID-19-infected individuals and a mortality rate of nearly 1000 cases per day, coupled with a shortage in an intensive care capacity. In return, several recommendations were implemented to mitigate the COVID-19 impact, including prioritising emergency services, cancellations of elective surgeries, redeploying surgical staff, mandatory SARS-CoV-2 testing for emergency surgery cases, minimising the operating team to essential members only, and measures for reducing the pre and intraoperative risk of infection [7]. The UK Corona TRAUMA Surge (UKCoTS) is a nationwide retrospective study that aimed to assess the impact of the COVID-19 pandemic on the postoperative mortality and morbidity of the patients who underwent trauma (bony or soft tissue procedure) surgery during the peak of the pandemic (April 2020).

Patients and methods

The present study was approved by the ethics and audit committee of all participating centres. The need for written informed consent was waived due to the retrospective nature of the study. The present manuscript was prepared in concordance with the STROBE guideline [20].

Design and patients

The UKCoTS, a part of the COVID Research group of the Royal College of Surgeons in England, was a retrospective multi-centre study that retrieved the data of patients who underwent trauma surgery across 50 centres in England, Wales, Scotland, and Ireland during the peak of the pandemic (April 2020). Investigators from the participating hospitals were invited to participate in the UKCoTS study during the Royal College of Surgeons (London) COVID-19 research team meeting. Sites’ investigators were required to retrieve both electronic and paper records of all patients who underwent trauma surgery, regardless of its type, from April 1 to April 30, 2020 (the peak of the pandemic) and 2019 (to serve as a control group). There were no restrictions regarding age, sex, or type of anaesthesia. The urgency of surgery was defined as immediate, urgent, expedited, or elective, according to National Confidential Enquiry into Patient Outcome and Death (NCEPOD) guidelines.

Data collection

The data were collected remotely using a standardised Excel spreadsheet at each participating site. The collected data included demographic characteristics of the patients, comorbidities, nature of the procedure and its indication, procedure-related characteristics, time to surgery, pre and postoperative COVID-19 status, hospital stay, type of follow-up, 30-day postoperative complication, needs for reoperation, 30-day mortality, causes of death, and 60-day morbidity and mortality.

Statistical analysis

According to the procedure date (April 2020 versus April 2019), retrieved data were categorised into two groups. The data were summarised using a median with interquartile range (IQR) for continuous variables and numbers with percentages for categorical variables. The association between the date of procedure and continuous variables was tested using the Mann-Whitney U test, while categorical variables were compared using the chi-square or Fisher’s exact test. A two-tailed p-value was considered statistically significant at <0.05.

Results

A total of 2595 patients were operated on during April 2020, compared to 4426 patients during the same period in 2019. Patients operated on during April 2020 were significantly younger (p <0.001) and less likely to be males (p <0.001). Concerning comorbidities, patients operated on during 2020 were more likely to have cardiovascular diseases, pulmonary diseases, diabetes, and renal diseases (p <0.001). Besides, patients who were operated on in 2020 were more likely to have a higher American Society of Anaesthesiologists (ASA) status than patients operated on in 2019 (ASA us th=42% versus 30.6%, respectively, p <0.001). Regarding the urgency of surgery, more than two-thirds of 2020 surgeries were urgent, which was significantly higher than the percentage of urgent surgeries during 2019 (p <0.001). The median time to surgery was significantly shorter during 2020 compared to 2019 (1 (1–2) versus 1 (1–4) days, respectively, p <0.001). The contribution of trauma surgery to the overall surgery indications was significantly higher in 2020 than in 2019 (87.1% versus 80.2%, respectively, p <0.001). Notably, surgeries were less likely to be performed by registrars during 2020 than in 2019 (36.6% versus 44.8%, respectively, p <0.001), while surgeries were more likely to be performed under general anaesthesia during 2020 (p <0.001) (Table 1).

Table 1.

Comparison of pre- and intraoperative characteristics of the study population according to the year of operation

Variables Year 2020 (n =2595) Year 2019 (n =4426) p-value
Age in years n 2563 4394 <0.001
Median (IQR) 44 (71–85) 61 (32.8–80)
Sex n 2595 4412 <0.001
Male (%) 1087 (41.9) 2130 (48.1)
ASA grade (%) n 2508 4265 <0.001
I 685 (26.4) 1578 (35.7)
II 732 (28.2) 1325 (29.9)
III 901 (34.7) 1111 (25.1)
≥11 190 (7.3) 244 (5.5)
Urgency of surgery (%) n 2591 4419 <0.001
Elective 55 (2.1) 434 (9.8)
Expedited 679 (26.2) 1371 (31.0)
Immediate 36 (1.4) 52 (1.2)
Urgent 1821 (70.3) 2562 (58.0)
Polytrauma n 2590 4416 0.91
Yes (%) 77 (3.0) 126 (2.8)
Time to surgery in days n 2546 4308 <0.001
Median (IQR) 1 (1–2) 1 (1–4)
Indication for surgery (%) n 2595 4358 <0.001
Cancer 9 (0.3) 12 (0.3)
Infection 184 (7.1) 289 (6.5)
Invasive soft tissue procedure 82 (3.2) 266 (6)
Non-invasive soft tissue procedure 23 (0.9) 37 (0.8)
Others 27 (1.0) 180 (4.1)
Spine 11 (0.4) 23 (0.5)
Trauma 2259 (87.1) 3551 (80.2)
Grade Of surgeon (%) n 2415 4398 <0.001
Consultant 1236 (47.6) 1944 (43.9)
CT/SHO 29 (1.1) 86 (1.9)
Fellow 200 (7.7) 385 (8.7)
Registrar 950 (36.6) 1983 (44.8)
Type Of anaesthesia (%) n 2576 4310 <0.001
General 1371 (52.8) 3024 (68.3)
General and regional 269 (10.4) 491 (11.1)
Local 85 (3.3) 116 (2.6)
Regional 851 (32.8) 679 (15.3)
Tourniquet use (%) n 2558 4234 <0.001
No 762 (29.4) 1364 (30.8)
Not applicable 1133 (43.7) 1334 (30.1)
Yes 663 (25.5) 1536 (34.7)
Cardiovascular disease n 2588 4410 <0.001
Yes (%) 1072 (41.3) 1390 (31.4)
Pulmonary disease n 2591 4408 0.015
Yes (%) 428 (16.5) 640 (14.5)
Dementia n 2592 4407 <0.001
Yes (%) 371 (14.3) 318 (7.2)
Diabetes mellitus n 2592 4409 0.008
Yes (%) 285 (11.0) 408 (9.2)
Renal disease n 2592 4407 <0.001
Yes (%) 263 (10.1) 388 (6.5)

Association between the year of surgery and postoperative outcomes

Patients in 2020 were less likely to be followed up within a 30-day postoperative period than patients in 2019 (57.5% versus 75.6%, respectively, p <0.001). Out of the followed-up cohort, remote follow-up was more common in 2020 (Table 2).

Table 2.

Comparison of postoperative outcomes of the study population according to the year of operation

Variables Year 2020 (n =2595) Year 2019 (n =4426) p-value
Follow-up within 30 days n 2551 4384 <0.001
No follow-up 1085 (42.5) 1069 (24.4)
Remote surgical team 180 (7.1) 12 (0.3)
Remote therapy 24 (0.9) 1 (0.01)
Face-to-face surgical team 1168 (45.8) 3093 (69.9)
Face-to-face therapy 36 (1.4) 75 (1.7)
Face-to-face community 58 (2.2) 134 (3)
30-day outcome n 1481 819 0.028
Died on table 2 (0.1) 1 (0.1)
Died day 0 to 7 28 (1.9) 7 (0.9)
Died day 8 to 30 80 (5.4) 22 (2.7)
Alive and still in the hospital 84 (5.7) 44 (5.4)
Alive and in another hospital 23 (1.6) 16 (2)
Alive and in a rehab unit 116 (7.8) 62 (7.6)
Alive and at home 1148 (77.5) 667 (81.4)
Complications within 30 days n 2586 4150 <0.001
Yes (%) 536 (20.7) 1097 (26.4)
Reoperation within 30 days n 2585 4185 <0.001
Yes (%) 135 (5.2) 384 (9.2)
Morbidity within 60 days n <0.001
Yes (%) 411 (15.8) 607 (13.7)

The postoperative 30-day and 60-day mortality rates for the whole cohort were 6.3% and 14.5%, respectively. The 30-day mortality rate was significantly higher in 2020 than in 2019 (7.4% versus 3.7%, respectively, p <0.001). Patients who were operated on during 2020 were more likely to die within the 30-day postoperative period or alive in rehabilitation centres/hospitals than patients who were operated on during 2019 (p =0.028). Likewise, the 60-day mortality rate was significantly higher in 2020 than in 2019 (15.8% versus 13.7%, respectively, p <0.001; Table 2).

The overall 30-day rate of the study cohort was 24.2%. Surprisingly, patients who were operated on during 2020 were less likely to experience 30-day postoperative complications than those who were operated on during 2019 (20.7% versus 26.4%, respectively, p <0.001). The reoperation rate was lower amongst patients in 2020 (5.2% versus 9.2%, respectively, p <0.001). A similar trend was observed concerning the 60-day complication rate (Table 2).

Association between patients’ characteristics and outcomes and the preoperative COVID-19 test result (Table 3)

Table 3.

Comparison of patients by COVID-19 test result

COVID-19 negative COVID-19 positive COVID-19 unknown p-value
Number 658 151 1716
Preoperative COVID-19 symptoms = true (%) 84 (12.8) 58 (38.4) 14 (0.8) < 0.001
Complication 30 days = yes (%) 116 (17.6) 78 (51.7) 199 (11.6) < 0.001
Mortality 30 days = yes (%) 47 (7.1) 15 (9.9) 64 (3.7) < 0.001
Composite outcome 30 days = yes (%) 135 (20.5) 80 (53.0) 218 (12.7) < 0.001

Nearly 6% of patients had been identified with COVID-19 symptoms and had a positive preoperative swab test. All three (COVID-19 negative, COVID-19 positive, and patients with unknown COVID-19 status) groups had similar age and gender distributions. Most patients with either negative (43.2%) or positive (49%) test results were ASA grade III. Urgent surgeries predominated in all groups, with a small percentage of polytrauma patients. Trauma was the most common indication for surgery in all groups, followed by infection (p <0.05). Most surgeries were performed by consultants regardless of the test result. General anaesthesia was applied more in patients with positive or unknown preoperative COVID-19 status, whereas regional anaesthesia was used more in patients with negative tests (p <0.001). Patients with positive preoperative tests had significantly higher diabetes and cardiovascular, renal, pulmonary, and cognitive diseases (p <0.001). Preoperative COVID-19 symptoms were more evident amongst patients with positive preoperative tests with higher overall 30-day complications and mortality rates (p <0.001).

Discussion

The COVID-19 pandemic has exerted substantial healthcare, economic, and social burdens, which extended to affect surgical practice, particularly during the early waves of the pandemic. In the UK, surgical practices changed to accommodate the large number of COVID-19 patients needing hospitalisation; little is known about how such changes impacted the outcomes of patients undergoing surgery. The present nationwide study aimed to assess the impact of the COVID-19 pandemic on the postoperative mortality and morbidity of the patients who underwent trauma (bony or soft tissue procedure) surgery during the peak of the pandemic (April 2020). Our results highlighted that the surgical outcomes during the pandemic’s peak were inferior to those during the same period before the pandemic, reflecting a substantial impact of the changes in the surgical practices implemented during the early wave of the pandemic on patients’ outcomes.

As previously mentioned, several measures were implemented in the UK during the early wave of the pandemic, which might have extended to affect even emergency services. For example, several centres redeployed surgical staff to increase the readiness of intensive care services against the sheer volume of COVID-19 cases [21]. Besides, preventive measures towards the risk of intraoperative infection were employed, including minimising the operating team and preoperative COVID-19 screening [7]. While these measures aimed primarily to reduce the risk of in-hospital infection and increase the healthcare system’s capacity, several researchers proposed that these measures negatively affected surgical outcomes [2224]. Despite the increased mortality rate, our study highlighted a reduced morbidity rate in form of lower complications and reoperations, which may emphasise the role of implementing preventive measures. To the best of our knowledge, this is the first nationwide study assessing the difference in postoperative outcomes between the peak months of the pandemic and the same period from the previous year. In a single-centre study from Turkey, the rate of in-hospital mortality amongst patients undergoing emergency surgery was higher during the pandemic peak (March to May 2020) than during the same period in the previous year [25]. In a multi-centre report from Germany, in-hospital mortality was higher in 2020 than in the previous two years amongst patients who underwent surgical treatment [26]. Similarly, the international PREDICT study reported an increase in in-hospital mortality amongst surgical patients presented during the first wave of the COVID-19 pandemic [22]. The increase in the mortality rate during the pandemic may be attributed to delayed presentation of the patients due to fear of COVID-19 infection leading to more severe status at presentation, as well as the changes in in-hospital logistics leading to delayed diagnosis and intensive care capacities [27].

On the other hand, we found that the rate of postoperative complications was lower during the peak of the pandemic than in the same period from the previous year. Such findings run in line with previous reports showing either positive or no impact of the COVID-19 pandemic on postoperative complications [26, 28, 29].

During the COVID-19 pandemic, the focus of healthcare centres was directed towards the urgent surgeries rather than elective surgeries, in order to preserve human resources and infrastructure, which resulted in reducing the number of major elective surgery procedures performed. Some investigators believe that this change in the surgical practice, performing more urgent surgeries, may contribute to the high mortality rates, regardless of the direct effect of COVID-19. Minto et al. compared elective and emergency surgeries in terms of postoperative mortality and morbidity during the COVID-19 pandemic. Their findings showed that the overall all-cause 30-day mortality was 3.6% in the emergency setting compared to 0.79% in the elective setting. Moreover, mortality was higher in patients with positive COVID-19 compared to those with negative COVID-19 (14.6% vs 1.4%, p< 0.001), respectively. The logistic regression analysis demonstrated a significant association between mortality and COVID-19-positive status (OR= 5.25, p<0.001) and emergency surgery (OR= 3.91, p<0.001) [30]. These findings highlighted that both COVID-19 status and emergency surgery may augment the risk of postoperative mortality; therefore, emergency and elective surgeries should be treated differently and should be separated in all studies to avoid the risk of bias. Based on our experience, we believe that the COVID-19 pandemic has a major effect on the mortality rate, regardless of the type of surgery; thus, we recommend treating both emergency and elective surgeries with the same degree of caution and implementing all preventive measures in both types of surgery. A Chinese series that included 34 patients with a perioperative diagnosis of COVID-19 infection undergoing elective surgery reports a mortality rate of 20.5%, requiring ICU management for respiratory failure in 44.1% of patients [31]. This rate of mortality resembles the rates reported from emergency surgeries, which supports our hypothesis.

We acknowledge that the present study has some limitations. The retrospective nature of the study can increase the risk of misclassification bias and impact the generalizability of the study. Besides, recall bias might have been presented during data collection, affecting its reliability.

In conclusion, the present study shows that postoperative mortality was higher during the first wave of the COVID-19 pandemic, compared to the same period in 2019, but with lower rates of postoperative complications. The harmful impact of COVID-19 on postoperative mortality can be explained by the tendency to perform urgent surgeries only during the peak of the pandemic and the delayed presentation of the patients due to fear of COVID-19 infection. However, the favourable postoperative complication rates during the pandemic reflect that trauma surgery can be safely performed during COVID-19 and similar pandemics. Hence, a risk assessment tool should be developed for surgical emergency services during pandemics.

Acknowledgements

UKCoTS Collaborative—author list in Appendix.

Appendix

First name Surname Email
Arrowe Park Hospital, Wirral
Vijaya Bhalaik vijaybhalaik@nhs.net
Vasantha Ramsingh vasantha.ramsingh@nhs.net
Chelsea and Westminster NHS Foundation Trust
Rupen Dattani Rupen.dattani@nhs.net
Catrin Morgan Catrin.morgan@nhs.net
Zoe Burdon Zoe.burdo1@nhs.net
Cork University Hospital
James Harty jamesharty@me.com
Hany Elbardesy elbardecy@hotmail.com
Countess of Chester Hospital
Hafiz Iqbal Hafiz-javaid.iqbal@nhs.net
Hafiz Umer Hafiz.umer@nhs.net
Epsom & St. Helier University Hospital NHS Trust
Sandile Hlabangana s.hlabangana@nhs.net
Sohail Yousaf Sohail.yousaf@nhs.net
Aisha Razik Aisha.razik@nhs.net
John Radcliffe Hospital
Yusuf Hasan Dryusufomran@msn.com
Mohammad Iqbal Mohammad_0991@hotmail.com
Kettering General Hospital
Nomaan Sheikh Nomaan.sheikh2@nhs.net
Ashish Waghmare Ashih.waghmare@nhs.net
Sherwood Forrest Hospital
Joby John Joby.john1@nhs.net
Mina Abdalla Mina.abdalla@nhs.net
University Hospital Wishaw, NHS Lanarkshire
Christopher Gee Christopher.gee@lanarkshire.scot.nhs.uk
Alisdair Gilmour Alisdair.gilmour@nhs.net
Queen Elizabeth Hospital, London
Jagwant Singh Jastwant.singh1@nhs.net
Emma Fossett Emma.fossett1@nhs.net
Medway Maritime Hospital
Bijayendra Singh Bijayendra.singh@nhs.net
Emile Oliver Emile.oliver@nhs.net
Leighton Hospital Mid-Cheshire NHS Foundation Trust
Greville Farrar Grevillea.farrar@mcht.nhs.uk
Ayman Gabr Aymangabr@nhs.net
Milton Keynes University Hospital
Alexander Martin alexandermartin@nhs.net
North West Anglia NHS Foundation Trust
Michael Dunne Michael.dunne6@nhs.net
Rachael Fisher Rachael.fisher1@nhs.net
Princess Alexandra Hospital, Harlow
Simon Wimsey Simon.wimsey@nhs.net
Rishi Dhir Rishi.dhir@nhs.net
Vishvas Shetty Vishvas.shetty@nhs.net
Birmingham Heartlands, Goodhope Hospital
Feiran Wu Feirwan.wu@heartofengland.nhs.uk
Siddhant Kapoor Siddhant.kapoor@heartofengland.nhs.uk
Mohammedabbas Remtulla Mohammedabbas.remtulla@heartofengland.nhs.uk
Queen Elizabeth Hospital, Birmingham
Ansar Mahmood Ansar.mahmood@uhb.nhs.uk
Paul Hindle Paul.hindle@uhn.nhs.uk
Krishna Subbaraman Krishna.subbaraman@heartofengland.nhs.uk
Royal Berkshire Hospital NHS FT
Paolo Consigliere Paolo.consigliere@nhs.net
Ejaz Chaudhry Dr.aliejaz84@gmail.com
Russells Hall Hospital, Dudley
Fouad Chaudhry Fouad.chaudhry@nhs.net
Amir Khan Amir.khan7@nhs.net
Salisbury District Hospital
Ahmed Elmorsy ahmedelmorsy@nhs.net
Hossam Fraig Hossam.fraig@nhs.net
Sandwell and West Birmingham Hospitals NHS Trust
Saad Elashry Saad.elashry@nhs.net
Ramez Golmohamad Ramez.golmohamad@nhs.net
Laura Hartley L.hartley@nhs.net
Southport and Ormskirk NHS Trust
Walaa Elnahas Walaa.el-nahas@nhs.net
Karthikeyan Iyengar k.iyengar@nhs.net
Ciara Phibbs Ciara.phibbs@tuh.ie
Tallaght University Hospital
Mark Quinn Quinnmark1@gmail.com
Samir Eldeep Samir.eldeep@tuh.ie
West Hertfordshire NHS Trust
Mustafa Al-yaseen Mustafa.al-yassen@nhs.net
Abdelmonem Hassan Abdelmonem.hassan@nhs.net
Wexham Park Hospital, Slough
James Holton James.holton@nhs.net
Burhan Mirza Burhan.mirza1@nhs.net
Worcestershire Royal Hospital
Charles Docker
Sophie Howles Sophie.howles@nhs.net
Worcester Acute Hospitals NHS Trust (Alexandra Hospital)
Ismail Fathalla fathalla.ismail@gmail.com
Ahmed Elsayed Ahmed.elsayed2@nhs.net
Wrexham Maelor Hospital, Wrexham, North Wales
Yogesh Joshi Yogesh.joshi@wales.nhs.uk
Pritom Shenoy Pritom.shenoy@wales.nhs.uk
Wrightington Wigan and Leigh NHS Hospital Trust
Puneet Monga Catherine.greaves@wwl.nhs.uk
Mahmoud Bhingraj Mahmoud.bhingraj@wwl.nhs.uk
Wythenshawe Hospital
Amirul Islam Amirul.islam@mft.nhs.uk
Ahmed Aljawadi Ahmed.aljawadi@nhs.net
Anand Pillai Anand.pillai@mft.nhs.uk
St. Peter Hospital
Rohit Pala Rohit.pala@nhs.net
Arshad Khaleel a.khaleel@nhs.net
East Sussex Healthcare NHS Trust
Christopher To Christopher.to@nhs.net
Ann McCormark A.mccormark@nhs.net
East Lancashire NHS Trust Hospitals (ELHT)
Srikanth Mudiganty Srikanth.mudiganty@elht.nhs.uk
Syed Bokhari Awais.bokhari@elht.nhs.uk
North Tees and Hartlepool University Hospital NHS Foundation Trust
Richard Jeavons r.jeavons@nhs.net
Nimesh Jain n.jain1@nhs.net
Morcambe Bay NHS Trust (MBHT)
Gautam Talawadekar Gautam.talawadekar@mbht.nhs.uk
Milind Mehta Milind.mehta@mbht.nhs.uk
University of East London
Nadeem Qazi n.qazi@uel.ac.uk

Author contribution

Mohamed Imam, Antony Chi Fung Yiu, Ahmed Elgebaly, and Ali A Narvani contributed to the study’s conception and design. Material preparation was performed by Mohamed Imam, Antony Chi Fung Yiu, Anshul Sobti, Richard E Field, Zahra Jaffry, Hazem Ghaith, Paolo Consigliere, and Ali A Narvani. Data collection was performed by all authors and contributors. Data analysis was performed by Ahmed Elgebaly, Rawad Hassan, and Hassan Abdalla. The first draft of the manuscript was written by Mohamed Imam and Ahmed Elgebaly, and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Declarations

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. The present study was approved by the ethics and audit committee of all participating centres.

Consent to participate

The need for written informed consent was waived due to the retrospective nature of the study.

Consent for publication

Not applicable

Competing interests

The authors declare no competing interests.

Footnotes

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Mohamed Imam, Email: M.Imam@uel.ac.uk.

UKCoTS Collaborative:

Vijaya Bhalaik, Vasantha Ramsingh, Rupen Dattani, Catrin Morgan, Zoe Burdon, James Harty, Hany Elbardesy, Hafiz Iqbal, Hafiz Umer, Sandile Hlabangana, Sohail Yousaf, Aisha Razik, Yusuf Hasan, Mohammad Iqbal, Nomaan Sheikh, Ashish Waghmare, Joby John, Mina Abdalla, Christopher Gee, Alisdair Gilmour, Jagwant Singh, Emma Fossett, Bijayendra Singh, Emile Oliver, Greville Farrar, Ayman Gabr, Alexander Martin, Michael Dunne, Rachael Fisher, Simon Wimsey, Rishi Dhir, Vishvas Shetty, Feiran Wu, Siddhant Kapoor, Mohammedabbas Remtulla, Ansar Mahmood, Paul Hindle, Krishna Subbaraman, Ejaz Chaudhry, Fouad Chaudhry, Amir Khan, Ahmed Elmorsy, Hossam Fraig, Saad Elashry, Ramez Golmohamad, Laura Hartley, Walaa Elnahas, Karthikeyan Iyengar, Ciara Phibbs, Mark Quinn, Samir Eldeep, Mustafa Al-yaseen, Abdelmonem Hassan, James Holton, Burhan Mirza, Charles Docker, Sophie Howles, Ismail Fathalla, Ahmed Elsayed, Yogesh Joshi, Pritom Shenoy, Puneet Monga, Mahmoud Bhingraj, Amirul Islam, Ahmed Aljawadi, Anand Pillai, Rohit Pala, Arshad Khaleel, Christopher To, Ann McCormark, Srikanth Mudiganty, Syed Bokhari, Richard Jeavons, Nimesh Jain, Gautam Talawadekar, Milind Mehta, and Nadeem Qazi

References

  • 1.Cheema S, Ameduri M, Abraham A et al (2020) The COVID-19 pandemic: the public health reality. Epidemiol Infect 148. 10.1017/S0950268820002216 [DOI] [PMC free article] [PubMed]
  • 2.COVID-19 Map - Johns Hopkins Coronavirus Resource Center. https://coronavirus.jhu.edu/map.html. Accessed 4 Jan 2022
  • 3.Locatelli I, Trächsel B, Rousson V (2021) Estimating the basic reproduction number for COVID-19 in Western Europe. PLoS One 16. 10.1371/JOURNAL.PONE.0248731 [DOI] [PMC free article] [PubMed]
  • 4.Kokudo N, Sugiyama H. Hospital capacity during the COVID-19 pandemic. Glob Health Med. 2021;3:56–59. doi: 10.35772/GHM.2021.01031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Wu H, Soe MM, Konnor R et al (2021) Hospital capacities and shortages of healthcare resources among US hospitals during the coronavirus disease 2019 (COVID-19) pandemic, National Healthcare Safety Network (NHSN), March 27–July 14, 2020. Infect Control Hosp Epidemiol 1. 10.1017/ICE.2021.280 [DOI] [PMC free article] [PubMed]
  • 6.Mustafa S, Zhang Y, Zibwowa Z et al (2021) COVID-19 Preparedness and Response Plans from 106 countries: a review from a health systems resilience perspective. Health Policy Plan. 10.1093/HEAPOL/CZAB089 [DOI] [PMC free article] [PubMed]
  • 7.Al-Jabir A, Kerwan A, Nicola M, et al. Impact of the coronavirus (COVID-19) pandemic on surgical practice - Part 1. Int J Surg. 2020;79:168. doi: 10.1016/J.IJSU.2020.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.O’Rielly C, Ng-Kamstra J, Kania-Richmond A, et al. Surgery and COVID-19: a rapid scoping review of the impact of the first wave of COVID-19 on surgical services. BMJ Open. 2021;11:e043966. doi: 10.1136/BMJOPEN-2020-043966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.de Mauro D, Rovere G, Smimmo A, et al. COVID-19 pandemic: management of patients affected by SARS-CoV-2 in Rome COVID Hospital 2 Trauma Centre and safety of our surgical team. Int Orthop. 2020;44:2487–2491. doi: 10.1007/S00264-020-04715-6/TABLES/3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Zagra L, Faraldi M, Pregliasco F, et al. Changes of clinical activities in an orthopaedic institute in North Italy during the spread of COVID-19 pandemic: a seven-week observational analysis. Int Orthop. 2020;44:1591–1598. doi: 10.1007/S00264-020-04590-1/TABLES/9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Gupta R, Gupta J, Ammar H. Impact of COVID-19 on the outcomes of gastrointestinal surgery. Clin J Gastroenterol. 2021;14:932–946. doi: 10.1007/S12328-021-01424-4/TABLES/3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Fusini F, Massè A, Risitano S, et al. Should we operate on all patients with COVID-19 and proximal femoral fractures? An analysis of thirty, sixty, and ninety day mortality rates based on patients’ clinical presentation and comorbidity: a multicentric study in Northern Italy. Int Orthop. 2021;45:2499–2505. doi: 10.1007/S00264-021-05166-3/TABLES/3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Megaloikonomos PD, Thaler M, Igoumenou VG, et al. Impact of the COVID-19 pandemic on orthopaedic and trauma surgery training in Europe. Int Orthop. 2020;44:1611–1619. doi: 10.1007/S00264-020-04742-3/FIGURES/4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Vaishya R, Vaish A, Kumar A. Impact of COVID-19 on the practice of orthopaedics and trauma—an epidemiological study of the full pandemic year of a tertiary care centre of New Delhi. Int Orthop. 2021;45:1391–1397. doi: 10.1007/S00264-021-05021-5/FIGURES/5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Søreide K, Hallet J, Matthews JB, et al. Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services. Br J Surg. 2020;107:1250–1261. doi: 10.1002/BJS.11670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Aminian A, Safari S, Razeghian-Jahromi A, et al. COVID-19 outbreak and surgical practice: unexpected fatality in perioperative period. Ann Surg. 2020;272:e27–e29. doi: 10.1097/SLA.0000000000003925. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Narang A, Chan G, Aframian A, et al. Thirty-day mortality following surgical management of hip fractures during the COVID-19 pandemic: findings from a prospective multi-centre UK study. Int Orthop. 2021;45:23–31. doi: 10.1007/S00264-020-04739-Y/FIGURES/2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Winter Beatty J, Clarke JM, Sounderajah V, et al. Impact of the COVID-19 pandemic on emergency adult surgical patients and surgical services. Ann Surg. 2021;274:904–912. doi: 10.1097/SLA.0000000000005152. [DOI] [PubMed] [Google Scholar]
  • 19.Krutsri C, Singhatas P, Sumpritpradit P, et al. Impact of the COVID-19 pandemic on the outcome, morbidity, and mortality of acute care surgery patients: a retrospective cohort study. Int J Surg Open. 2021;28:50–55. doi: 10.1016/J.IJSO.2020.11.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Elm E von, Altman DG, Egger M et al (2014) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies *. Int J Surg 12:1495–1499. 10.1016/j.ijsu.2014.07.013 [DOI] [PubMed]
  • 21.Payne A, Rahman R, Bullingham R, et al. Redeployment of surgical trainees to intensive care during the COVID-19 Pandemic: evaluation of the impact on training and wellbeing. J Surg Educ. 2021;78:813. doi: 10.1016/J.JSURG.2020.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Winter Beatty J, Clarke JM, Sounderajah V, et al. Impact of the COVID-19 pandemic on emergency adult surgical patients and surgical services: an international multi-center cohort study and department survey. Ann Surg. 2021;274:904–912. doi: 10.1097/SLA.0000000000005152. [DOI] [PubMed] [Google Scholar]
  • 23.Futooh Z, Farouk N, Gad D. Impact of COVID 19 pandemic on surgical outcomes, a single center experience. Med J Cairo Univ. 2021;89:825–832. doi: 10.21608/MJCU.2021.168020. [DOI] [Google Scholar]
  • 24.Stöss C, Steffani M, Pergolini I, et al. Impact of the COVID-19 pandemic on surgical oncology in Europe: results of a European survey. Dig Surg. 2021;38:259–265. doi: 10.1159/000515186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Surek A, Ferahman S, Gemici E, et al. Effects of COVID-19 pandemic on general surgical emergencies: are some emergencies really urgent? Level 1 trauma center experience. Eur J Trauma Emerg Surg. 2021;47:647–652. doi: 10.1007/S00068-020-01534-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Hillebrandt KH, Moosburner S, Winter A et al (2022) The influence of the COVID-19 pandemic on surgical therapy and care: a cross-sectional study. BMC Surg 2022 22:1 22:1–11. 10.1186/S12893-022-01708-7 [DOI] [PMC free article] [PubMed]
  • 27.Reichert M, Sartelli M, Weigand MA et al (2020) Impact of the SARS-CoV-2 pandemic on emergency surgery services-a multi-national survey among WSES members. World J Emerg Surg 15. 10.1186/S13017-020-00341-0 [DOI] [PMC free article] [PubMed]
  • 28.Cano-Valderrama O, Morales X, Ferrigni CJ, et al. Acute Care Surgery during the COVID-19 pandemic in Spain: Changes in volume, causes and complications. A multicentre retrospective cohort study. Int J Surg. 2020;80:157–161. doi: 10.1016/J.IJSU.2020.07.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Gopal K, Krishna N, Jose R, et al. Effects of the COVID-19 pandemic on cardiac surgery practice and outcomes. J Chest Surg. 2022;55:61–68. doi: 10.5090/JCS.21.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Minto T, Abdelrahman T, Jones L, et al. Safety of maintaining elective and emergency surgery during the COVID-19 pandemic with the introduction of a Protected Elective Surgical Unit (PESU): a cross-specialty evaluation of 30-day outcomes in 9,925 patients undergoing surgery in a University Health Board. Surg Open Sci. 2022;10:168–173. doi: 10.1016/J.SOPEN.2022.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Lei S, Jiang F, Su W et al (2020) Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine 21. 10.1016/J.ECLINM.2020.100331 [DOI] [PMC free article] [PubMed]

Articles from International Orthopaedics are provided here courtesy of Nature Publishing Group

RESOURCES